Notice Information
Notice Title
Tier 2 Dermatology Service for NHS MSE ICB
Notice Description
This is a contract award notice and is intended to provide notice of NHS Mid and South Essex Integrated Care Board (herein "the Authority")'s intention to award a contract to deliver Tier 2 Dermatology Services to the patients within Mid and South Essex's geographical footprint. This contract award notice is made following the Authority's publication of the voluntary ex ante transparency notice (Notice Number: 2023/S 000-037585) on the 21st December 2023 which outlined the rationale and reasoning for the Authority's decision to award this contract, under Regulation 32 (2) (c) of the Public Contract Regulations 2015 ("PCR 2015") (as amended The Public Procurement (Amendment etc.) (EU Exit) Regulations 2020). In line with best practice, the Authority has observed the voluntary 10-day standstill period from the publication date of the voluntary ex-ante Notice before awarding the contract, pursuant to Regulation 99 (3) (c) of the Public Contract Regulations 2015 (as amended (EU Exit) 2020 etc.) The Authority intends to enter into a contract for 12 months, from 01st April 2024 - 31st March 2025 . The aggregate contract value is forecasted at PS1,027,687.
Lot Information
Lot 1
This is a contract award notice and is intended to provide notice of NHS Mid and South Essex Integrated Care Board (herein "the Authority")'s intention to award a contract to deliver Tier 2 Dermatology Services to the patients within Mid and South Essex's geographical footprint. This contract award notice is made following the Authority's publication of the voluntary ex ante transparency notice (Notice Number: 2023/S 000-037585) on the 21st December 2023 which outlined the rationale and reasoning for the Authority's decision to award this contract, under Regulation 32 (2) (c) of the Public Contract Regulations 2015 ("PCR 2015") (as amended The Public Procurement (Amendment etc.) (EU Exit) Regulations 2020). In line with best practice, the Authority has observed the voluntary 10-day standstill period from the publication date of the voluntary ex-ante Notice before awarding the contract, pursuant to Regulation 99 (3) (c) of the Public Contract Regulations 2015 (as amended (EU Exit) 2020 etc.) The Service to which this procurement relates fall within Schedule 3 of the Public Contracts Regulations 2015 as amended by as amended by The Public Procurement (Amendment etc.) (EU Exit) Regulations 2020, (the "Regulations"). As such, the Authority does not intend to hold itself bound by any of the Regulations, save those applicable to Schedule 3 Services. The voluntary ex ante transparency notice provided notice of NHS Mid and South Essex Integrated Care Board (herein "the Authority")'s intention to award a contract to deliver Tier 2 Dermatology Services to the patients within Mid and South Essex's geographical footprint. The contract will be for 12 months, from 01st April 2024 - 31st March 2025 . The aggregate contract value is forecasted at PS1,027,687. As of July 2022, the Integrated Care Board was formed and replaced the previous Clinical Commissioning Groups (CCGs). NHS MSE ICB superseded the 5 CCGs and the ICB is undergoing an organisational restructure and at the current time (the time of this notice being published, October 2023), therefore longer-term strategies across all sectors are under discussion and longer term commissioning decisions and or procurements cannot take place until these legal arrangements are confirmed. As a result, the Authority will then have to review, assess and align services that were previously commissioned by the CCGs, now ICB, within their own localities and covering various contract terms across the Mid and South Essex footprint. The Authority has therefore taken the decision to award this Tier 2 Dermatology Service (which was previously for CPR and Southend CCG) to incumbent provider Mid and South Essex NHS Foundation Trust (MSEFT). The provider is considered most technically capable of providing the most economically advantageous solution to the Authority under the current environment whilst the ICB undergoes restructure, review and alignment of contracts. The Authority is applying the NHS Standard Contract Terms and Conditions to support a combination of services, all of which are part funded a under a single clinical contract, to ensure appropriate clinical governance and service delivery quality as well as consistency of service to patients. The Authority is commencing a procurement-process for it's own Tier 2 Dermatology Services for the whole of the ICB and will publish appropriate Notices accordingly to communicate any such future changes and opportunities to the market, once final. Additional information: The Service to which this procurement relates fall within Schedule 3 of the Public Contracts Regulations 2015 as amended by as amended by The Public Procurement (Amendment etc.) (EU Exit) Regulations 2020, (the "Regulations"). As such, the Contracting Authority does not intend to hold itself bound by any of the Regulations, save those applicable to Schedule 3 Services.
Procurement Information
The Authority has taken a decision to award a contract to the incumbent provider as it is considered to be the most technically capable provider in the current environment, whilst the ICB undergoes this transition period, to ensure quality, safety and consistency in provision of care that meet the needs of the population during this transition period. The Authority will publish appropriate Notices accordingly to communicate any such future changes to the market, once final. This contract award notice is made following the Authority's publication of the voluntary ex ante transparency notice (Notice Number: 2023/S 000-037585) on the 21st December 2023 which outlined the rationale and reasoning for the Authority's decision to award this contract, under Regulation 32 (2) (c) of the Public Contract Regulations 2015 ("PCR 2015") (as amended The Public Procurement (Amendment etc.) (EU Exit) Regulations 2020). In line with best practice, the Authority has observed the voluntary 10-day standstill period from the publication date of the voluntary ex-ante Notice before awarding the contract, pursuant to Regulation 99 (3) (c) of the Public Contract Regulations 2015 (as amended (EU Exit) 2020 etc.)
Notice Details
Publication & Lifecycle
- Open Contracting ID
- ocds-h6vhtk-0428f6
- Publication Source
- Find A Tender Service
- Latest Notice
- https://www.find-tender.service.gov.uk/Notice/000726-2024
- Current Stage
- Award
- All Stages
- Award
Procurement Classification
- Notice Type
- Award Notice
- Procurement Type
- Standard
- Procurement Category
- Services
- Procurement Method
- Limited
- Procurement Method Details
- Award procedure without prior publication of a call for competition
- Tender Suitability
- Not specified
- Awardee Scale
- Large
Common Procurement Vocabulary (CPV)
- CPV Divisions
85 - Health and social work services
-
- CPV Codes
85100000 - Health services
Notice Value(s)
- Tender Value
- Not specified
- Lots Value
- Not specified
- Awards Value
- Not specified
- Contracts Value
- £1,027,687 £1M-£10M
Notice Dates
- Publication Date
- 9 Jan 20242 years ago
- Submission Deadline
- Not specified
- Future Notice Date
- Not specified
- Award Date
- 15 Oct 20232 years ago
- Contract Period
- Not specified - Not specified
- Recurrence
- Not specified
Notice Status
- Tender Status
- Complete
- Lots Status
- Cancelled
- Awards Status
- Active
- Contracts Status
- Active
Buyer & Supplier
Contracting Authority (Buyer)
- Main Buyer
- NHS MID AND SOUTH ESSEX INTEGRATED CARE BOARD
- Contact Name
- NHS Mid and South Essex Integrated Care Board
- Contact Email
- cariad.burgess@attain.co.uk
- Contact Phone
- Not specified
Buyer Location
- Locality
- BASILDON
- Postcode
- SS14 3HG
- Post Town
- Southend-on-Sea
- Country
- England
-
- Major Region (ITL 1)
- TLH East (England)
- Basic Region (ITL 2)
- TLH3 Essex
- Small Region (ITL 3)
- TLH37 Essex Thames Gateway
- Delivery Location
- TLH3 Essex
-
- Local Authority
- Basildon
- Electoral Ward
- Fryerns
- Westminster Constituency
- Basildon and Billericay
Further Information
Open Contracting Data Standard (OCDS)
View full OCDS Record for this contracting process
The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.
{
"tag": [
"compiled"
],
"id": "ocds-h6vhtk-0428f6-2024-01-09T19:49:05Z",
"date": "2024-01-09T19:49:05Z",
"ocid": "ocds-h6vhtk-0428f6",
"description": "Mid and South Essex NHS Foundation Trusts Postal address: Southend University Hospital, Prittlewell Chase, Westcliff-on-Sea, Essex, SS0 0RY, Broomfield Hospital, Court Rd, Broomfield, Chelmsford CM1 7ET, Basildon Hospital, Nether Mayne, Basildon SS16 5NL",
"initiationType": "tender",
"tender": {
"id": "ACE-0716-2023-MSE",
"legalBasis": {
"id": "32014L0024",
"scheme": "CELEX"
},
"title": "Tier 2 Dermatology Service for NHS MSE ICB",
"status": "complete",
"classification": {
"scheme": "CPV",
"id": "85100000",
"description": "Health services"
},
"mainProcurementCategory": "services",
"description": "This is a contract award notice and is intended to provide notice of NHS Mid and South Essex Integrated Care Board (herein \"the Authority\")'s intention to award a contract to deliver Tier 2 Dermatology Services to the patients within Mid and South Essex's geographical footprint. This contract award notice is made following the Authority's publication of the voluntary ex ante transparency notice (Notice Number: 2023/S 000-037585) on the 21st December 2023 which outlined the rationale and reasoning for the Authority's decision to award this contract, under Regulation 32 (2) (c) of the Public Contract Regulations 2015 (\"PCR 2015\") (as amended The Public Procurement (Amendment etc.) (EU Exit) Regulations 2020). In line with best practice, the Authority has observed the voluntary 10-day standstill period from the publication date of the voluntary ex-ante Notice before awarding the contract, pursuant to Regulation 99 (3) (c) of the Public Contract Regulations 2015 (as amended (EU Exit) 2020 etc.) The Authority intends to enter into a contract for 12 months, from 01st April 2024 - 31st March 2025 . The aggregate contract value is forecasted at PS1,027,687.",
"lots": [
{
"id": "1",
"description": "This is a contract award notice and is intended to provide notice of NHS Mid and South Essex Integrated Care Board (herein \"the Authority\")'s intention to award a contract to deliver Tier 2 Dermatology Services to the patients within Mid and South Essex's geographical footprint. This contract award notice is made following the Authority's publication of the voluntary ex ante transparency notice (Notice Number: 2023/S 000-037585) on the 21st December 2023 which outlined the rationale and reasoning for the Authority's decision to award this contract, under Regulation 32 (2) (c) of the Public Contract Regulations 2015 (\"PCR 2015\") (as amended The Public Procurement (Amendment etc.) (EU Exit) Regulations 2020). In line with best practice, the Authority has observed the voluntary 10-day standstill period from the publication date of the voluntary ex-ante Notice before awarding the contract, pursuant to Regulation 99 (3) (c) of the Public Contract Regulations 2015 (as amended (EU Exit) 2020 etc.) The Service to which this procurement relates fall within Schedule 3 of the Public Contracts Regulations 2015 as amended by as amended by The Public Procurement (Amendment etc.) (EU Exit) Regulations 2020, (the \"Regulations\"). As such, the Authority does not intend to hold itself bound by any of the Regulations, save those applicable to Schedule 3 Services. The voluntary ex ante transparency notice provided notice of NHS Mid and South Essex Integrated Care Board (herein \"the Authority\")'s intention to award a contract to deliver Tier 2 Dermatology Services to the patients within Mid and South Essex's geographical footprint. The contract will be for 12 months, from 01st April 2024 - 31st March 2025 . The aggregate contract value is forecasted at PS1,027,687. As of July 2022, the Integrated Care Board was formed and replaced the previous Clinical Commissioning Groups (CCGs). NHS MSE ICB superseded the 5 CCGs and the ICB is undergoing an organisational restructure and at the current time (the time of this notice being published, October 2023), therefore longer-term strategies across all sectors are under discussion and longer term commissioning decisions and or procurements cannot take place until these legal arrangements are confirmed. As a result, the Authority will then have to review, assess and align services that were previously commissioned by the CCGs, now ICB, within their own localities and covering various contract terms across the Mid and South Essex footprint. The Authority has therefore taken the decision to award this Tier 2 Dermatology Service (which was previously for CPR and Southend CCG) to incumbent provider Mid and South Essex NHS Foundation Trust (MSEFT). The provider is considered most technically capable of providing the most economically advantageous solution to the Authority under the current environment whilst the ICB undergoes restructure, review and alignment of contracts. The Authority is applying the NHS Standard Contract Terms and Conditions to support a combination of services, all of which are part funded a under a single clinical contract, to ensure appropriate clinical governance and service delivery quality as well as consistency of service to patients. The Authority is commencing a procurement-process for it's own Tier 2 Dermatology Services for the whole of the ICB and will publish appropriate Notices accordingly to communicate any such future changes and opportunities to the market, once final. Additional information: The Service to which this procurement relates fall within Schedule 3 of the Public Contracts Regulations 2015 as amended by as amended by The Public Procurement (Amendment etc.) (EU Exit) Regulations 2020, (the \"Regulations\"). As such, the Contracting Authority does not intend to hold itself bound by any of the Regulations, save those applicable to Schedule 3 Services.",
"awardCriteria": {
"criteria": [
{
"name": "Quality",
"type": "quality",
"description": "100"
},
{
"type": "price",
"description": "100"
}
]
},
"hasOptions": false,
"status": "cancelled"
}
],
"items": [
{
"id": "1",
"deliveryAddresses": [
{
"region": "UKH3"
},
{
"region": "UKH3"
},
{
"region": "UKH3"
}
],
"relatedLot": "1"
}
],
"procurementMethod": "limited",
"procurementMethodDetails": "Award procedure without prior publication of a call for competition",
"procurementMethodRationaleClassifications": [
{
"scheme": "TED_PT_AWARD_CONTRACT_WITHOUT_CALL",
"id": "D_EXTREME_URGENCY",
"description": "Extreme urgency brought about by events unforeseeable for the contracting authority/entity and in accordance with the strict conditions stated in the directive"
}
],
"procurementMethodRationale": "The Authority has taken a decision to award a contract to the incumbent provider as it is considered to be the most technically capable provider in the current environment, whilst the ICB undergoes this transition period, to ensure quality, safety and consistency in provision of care that meet the needs of the population during this transition period. The Authority will publish appropriate Notices accordingly to communicate any such future changes to the market, once final. This contract award notice is made following the Authority's publication of the voluntary ex ante transparency notice (Notice Number: 2023/S 000-037585) on the 21st December 2023 which outlined the rationale and reasoning for the Authority's decision to award this contract, under Regulation 32 (2) (c) of the Public Contract Regulations 2015 (\"PCR 2015\") (as amended The Public Procurement (Amendment etc.) (EU Exit) Regulations 2020). In line with best practice, the Authority has observed the voluntary 10-day standstill period from the publication date of the voluntary ex-ante Notice before awarding the contract, pursuant to Regulation 99 (3) (c) of the Public Contract Regulations 2015 (as amended (EU Exit) 2020 etc.)"
},
"awards": [
{
"id": "037585-2023-1",
"relatedLots": [
"1"
],
"status": "active",
"hasSubcontracting": true,
"suppliers": [
{
"id": "GB-FTS-96747",
"name": "Mid and South Essex NHS Foundation Trust"
}
]
},
{
"id": "000656-2024-1",
"relatedLots": [
"1"
],
"title": "Tier 2 - Dermatology",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-98361",
"name": "Mid and South Essex NHS Foundation Trust"
}
]
},
{
"id": "000726-2024-1",
"relatedLots": [
"1"
],
"title": "Tier 2 - Dermatology",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-98361",
"name": "Mid and South Essex NHS Foundation Trust"
}
]
}
],
"parties": [
{
"id": "GB-FTS-101203",
"name": "NHS Mid and South Essex Integrated Care Board",
"identifier": {
"legalName": "NHS Mid and South Essex Integrated Care Board"
},
"address": {
"locality": "Basildon",
"region": "UKH3",
"postalCode": "SS14 3HG",
"countryName": "United Kingdom"
},
"contactPoint": {
"email": "cariad.burgess@attain.co.uk"
},
"roles": [
"buyer"
],
"details": {
"url": "https://www.midandsouthessex.ics.nhs.uk",
"classifications": [
{
"scheme": "TED_CA_TYPE",
"id": "BODY_PUBLIC",
"description": "Body governed by public law"
},
{
"scheme": "COFOG",
"id": "07",
"description": "Health"
}
]
}
},
{
"id": "GB-FTS-96747",
"name": "Mid and South Essex NHS Foundation Trust",
"identifier": {
"legalName": "Mid and South Essex NHS Foundation Trust"
},
"address": {
"streetAddress": "Southend University Hospital, Prittlewell Chase, Westcliff-on-Sea, Essex, SS0 0RY, Broomfield Hospital, Court Rd, Broomfield, Chelmsford CM1 7ET, Basildon Hospital, Nether Mayne, Basildon SS16 5NL",
"locality": "Basildon",
"region": "UKH3",
"postalCode": "SS16 5NL",
"countryName": "United Kingdom"
},
"roles": [
"supplier"
],
"details": {
"url": "https://www.mse.nhs.uk/about-us",
"scale": "large"
}
},
{
"id": "GB-FTS-96746",
"name": "High Court Justice of England and Wales",
"identifier": {
"legalName": "High Court Justice of England and Wales"
},
"address": {
"streetAddress": "The Strand",
"locality": "London",
"postalCode": "WC2A 2LL",
"countryName": "United Kingdom"
},
"roles": [
"reviewBody"
]
},
{
"id": "GB-FTS-2645",
"name": "High Court of Justice of England and Wales",
"identifier": {
"legalName": "High Court of Justice of England and Wales"
},
"address": {
"streetAddress": "Strand",
"locality": "London",
"postalCode": "WC2A 2LL",
"countryName": "United Kingdom"
},
"roles": [
"reviewBody"
]
},
{
"id": "GB-FTS-73493",
"name": "NHS Mid and South Essex Integrated Care Board",
"identifier": {
"legalName": "NHS Mid and South Essex Integrated Care Board"
},
"address": {
"streetAddress": "Phoenix House, Christopher Martin Rd,",
"locality": "Basildon",
"postalCode": "SS14 3HG",
"countryName": "United Kingdom",
"region": "UKH3"
},
"roles": [
"buyer",
"mediationBody"
],
"details": {
"url": "https://www.midandsouthessex.ics.nhs.uk",
"classifications": [
{
"scheme": "TED_CA_TYPE",
"id": "BODY_PUBLIC",
"description": "Body governed by public law"
},
{
"scheme": "COFOG",
"id": "07",
"description": "Health"
}
]
},
"contactPoint": {
"name": "NHS Mid and South Essex Integrated Care Board",
"email": "cariad.burgess@attain.co.uk"
},
"additionalContactPoints": [
{
"email": "cariad.burgess@attain.co.uk"
}
]
},
{
"id": "GB-FTS-98361",
"name": "Mid and South Essex NHS Foundation Trust",
"identifier": {
"legalName": "Mid and South Essex NHS Foundation Trust"
},
"address": {
"streetAddress": "Nether Mayne,",
"locality": "Basildon",
"region": "UKH3",
"postalCode": "SS16 5NL",
"countryName": "United Kingdom"
},
"roles": [
"supplier"
],
"details": {
"url": "https://www.mse.nhs.uk/about-us",
"scale": "large"
}
}
],
"buyer": {
"id": "GB-FTS-73493",
"name": "NHS Mid and South Essex Integrated Care Board"
},
"contracts": [
{
"id": "037585-2023-1",
"awardID": "037585-2023-1",
"status": "active",
"value": {
"amount": 1027687,
"currency": "GBP"
},
"dateSigned": "2023-10-16T00:00:00+01:00"
},
{
"id": "000656-2024-1",
"awardID": "000656-2024-1",
"title": "Tier 2 - Dermatology",
"status": "active",
"value": {
"amount": 1027687,
"currency": "GBP"
},
"dateSigned": "2023-10-16T00:00:00+01:00"
},
{
"id": "000726-2024-1",
"awardID": "000726-2024-1",
"title": "Tier 2 - Dermatology",
"status": "active",
"value": {
"amount": 1027687,
"currency": "GBP"
},
"dateSigned": "2023-10-16T00:00:00+01:00"
}
],
"language": "en",
"bids": {
"statistics": [
{
"id": "1",
"measure": "bids",
"relatedLot": "1",
"value": 1
},
{
"id": "2",
"measure": "smeBids",
"relatedLot": "1",
"value": 1
},
{
"id": "3",
"measure": "foreignBidsFromEU",
"relatedLot": "1",
"value": 1
},
{
"id": "4",
"measure": "foreignBidsFromNonEU",
"relatedLot": "1",
"value": 1
},
{
"id": "5",
"measure": "electronicBids",
"relatedLot": "1",
"value": 1
},
{
"id": "6",
"measure": "bids",
"relatedLot": "1",
"value": 1
},
{
"id": "7",
"measure": "smeBids",
"relatedLot": "1",
"value": 1
},
{
"id": "8",
"measure": "foreignBidsFromEU",
"relatedLot": "1",
"value": 1
},
{
"id": "9",
"measure": "foreignBidsFromNonEU",
"relatedLot": "1",
"value": 1
},
{
"id": "10",
"measure": "electronicBids",
"relatedLot": "1",
"value": 1
}
]
}
}